Target intelligence / Profile preview

Hepatocyte plasma membrane lipids

Molecular classification
Other
01

Overview

Hepatocyte plasma membrane lipids constitute the structural and functional boundary of liver cells, primarily composed of phospholipids, cholesterol, and sphingolipids (Journal of Lipid Research, 2021). These lipids are not merely structural; they play a critical role in regulating membrane fluidity, signal transduction, and the activity of membrane-bound proteins such as transporters and receptors (StatPearls, 2023). In various liver diseases, including non-alcoholic steatohepatitis (NASH) and cholestasis, the composition and integrity of these lipids are often compromised, leading to cellular dysfunction and apoptosis (Journal of Clinical and Experimental Hepatology, 2016). Therapeutic strategies targeting these lipids involve the use of membrane-stabilizing agents like ursodeoxycholic acid or synthetic lipid conjugates like Aramchol, which aim to restore membrane homeostasis and modulate lipid metabolism (Galmed Pharmaceuticals, 2023). By altering the biophysical properties of the hepatocyte membrane, these drugs can mitigate the progression of liver fibrosis and inflammation. Furthermore, the lipid composition of the hepatocyte membrane is a key factor in the entry of hepatotropic viruses, making it a target for antiviral research (PubMed, 2022).

Other names
Liver cell membrane lipidsHepatocyte membrane phospholipidsHepatocyte surface lipids
02

Mechanism of action

Modulation of membrane fluidity and stabilization of the lipid bilayer to prevent cellular damage and regulate lipid metabolism (StatPearls, 2023; Galmed Pharmaceuticals, 2023).

03

Biological functions

Signal transductionOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Non-specific membrane disruptionAlteration of systemic lipid profiles
06

Interacting drugs

Aramchol

2 more in the full profile.

07

Biomarkers

Phosphatidylcholine/phosphatidylethanolamine ratioMembrane fluidity index

Beyond the preview

Go deeper on Hepatocyte plasma membrane lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte plasma membrane lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call